Negative impact of surgical site infection on long-term outcomes after hepatic resection for colorectal liver metastases

Anticancer Research

Volumn 33, Issue 4, 2013, Pages 1697-1704

  Haruki, Koichiro ^a   Shiba, Hiroaki ^a   Fujiwara, Yuki ^a   Furukawa, Kenei ^a   Wakiyama, Shigeki ^a   Ogawa, Masaichi ^a   Ishida, Yuichi ^a   Misawa, Takeyuki ^a   Yanaga, Katsuhiko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal liver metastases; Glasgow prognostic score; Surgical site infection; Systemic inflammatory response

Indexed keywords

FRESH FROZEN PLASMA;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER PROGNOSIS; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE FREE SURVIVAL; ELECTIVE SURGERY; FEMALE; HEALTH IMPACT ASSESSMENT; HUMAN; INTRAOPERATIVE PERIOD; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL INFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; INFECTION; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84876778770     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Fong Y, Fortner J, Sun RL, Brennan MF and Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-318, 1999.
2. Malik HZ, Prasad KR, Halazun KJ, Aldoori A, Al-Mukhtar A, Gomez D, Lodge JP and Toogood GJ: Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 246: 806-814, 2007. (Pubitemid 350035657)
3. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ and Rees M: Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Br J Cancer 94: 982-999, 2006.
4. Laurent C, Sa Cunha A, Couderc P, Rullier E and Saric J: Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 90: 1131-1136, 2003. (Pubitemid 37152173)
5. Rees M, Tekkis PP, Welsh FK, O'Rourke T and John TG: Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: A multifactorial model of 929 patients. Ann Surg 247: 125-135, 2008.
6. Virani S, Michaelson JS, Hutter MM, Lancaster RT, Warshaw AL, Henderson WG, Khuri SF and Tanabe KK: Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg 204: 1284-1292, 2007. (Pubitemid 46819089)
7. Dimick JB, Pronovost PJ, Cowan JA and Lipsett PA: Complications and costs after high-risk surgery: Where should we focus quality improvement initiatives? J Am Coll Surg 196: 671-678, 2003. (Pubitemid 36560195)
8. Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA and Kumbhani DJ; Participants in the VA National Surgical Quality Improvement Program: Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg 242: 326-341, 2005.
9. Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M, Brennan MF and Rusch VW: The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg 198: 42-50, 2004. (Pubitemid 38201087)
10. Law WL, Choi HK, Lee YM and Ho JW: The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol 14: 2559-66, 2007. (Pubitemid 47389572)
11. McArdle CS, McMillan DC and Hole DJ: Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg 92: 1150-1154, 2005. (Pubitemid 41284881)
12. Ito H, Are C, Gonen M, D'Angelica M, Dematteo RP, Kemeny NE, Fong Y, Blumgart LH and Jarnagin WR: Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg 247: 994-1002, 2008. (Pubitemid 351770420)
13. Schiesser M, Chen JW, Maddern GJ and Padbury RT: Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases. J Gastrointest Surg 12: 1054-1060, 2008.
14. Farid SG, Aldouri A, Morris-Stiff G, Khan AZ, Toogood GJ, Lodge JP and Prasad KR: Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg 251: 91-100, 2010.
15. Neal CP, Mann CD, Garcea G, Briggs CD, Dennison AR and Berry DP: Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases. Arch Surg 146: 471-478, 2011.
16. Proctor MJ, Morrison DS, Talwar D, Balmer SM, O'Reilly DS, Foulis AK, Horgan PG and McMillan DC: An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumor site: A Glasow inflammation outcome study. Br J Cancer 104: 726-734, 2011.
17. McMillan DC: An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67: 257-262, 2008.
18. Moyes LH, Leitch EF, McKee RF, Anderson JH, Horgan PG and McMillan DC: Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer 100: 1236-1239, 2009.
19. Miyagawa S, Makuuchi M, Kawasaki S and Kakazu T: Criteria for safe hepatic resection. Am J Surg 169: 589-594, 1995.
20. Japanese Bureau of Medical Safety, Ministry of Health and Welfare. Guidelines for Administering Blood Preparations. Medical and Pharmaceutial Notification No. 715, 10 June, 1999.
21. Lundy J and Ford CM: Surgery, trauma and immune suppression; Evolving the mechanism. Ann Surg 197: 434-438, 1983. (Pubitemid 13112785)
22. Nespoli A, Gianotti L, Bovo G, Brivio F, Nespoli L and Totis M: Impact of postoperative infections on survival in colon cancer patients. Surg Infect 7: S41-43, 2006.
23. Abramovitch R, Marikovsky M, Meir G and Neeman M: Stimulation of tumor growth by wound-derived growth factors. Br J Cancer 79: 1392-1398, 1999. (Pubitemid 29116795)
24. Horn F, Henze C and Heidrich K: Interleukin-6 signal transduction and lymphocyte function. Immunobiology 202: 151-167, 2000. (Pubitemid 30642514)
25. Menetrier-Caux C, Montmain G, Dieu MC, Bain C, Favrot MC, Caux C and Blay JY: Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: Role of interleukin-6 and macrophage colony-stimulating factor. Blood 92: 4778-4791, 1998. (Pubitemid 29005881)
26. Mynster T, Christensen IJ, Moesgaard F and Nielsen HJ: Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg 87: 1553-1562, 2000.
27. Panis Y, Ribeiro J, Chrétien Y and Nordlinger B: Dormant liver metastases: An experimental study. Br J Surg 79: 221-223, 1992.
28. Taichman NS, Young S, Cruchley AT, Taylor P and Paleolog E: Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol 62: 397-400, 1997. (Pubitemid 27431612)
29. Maniwa Y, Okada M, Ishii N and Kiyooka K: Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer. Chest 114: 1668-1675, 1998. (Pubitemid 128487491)
30. Gruttadauria S, Saint Georges Chaumet M, Pagano D, Marsh JW, Bartoccelli C, Cintorino D, Arcadipane A, Vizzini G, Spada M and Gridelli B: Impact of blood transfusion on early outcome of liver resection for colorectal hepatic metastases. J Surg Oncol 103: 140-147, 2011.
31. Forrest LM, McMillan DC, McArdle CS, Angerson WJ and Dunlop DJ: Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small cell lung cancer. Br J Cancer 89: 1028-1030, 2003. (Pubitemid 37239206)
32. Crumley AB, McMillan DC, McKernan M, Going JJ, Shearer CJ and Stuart RC: An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer 94: 1568-1571, 2006. (Pubitemid 43924914)
33. Glen P, Jamieson NB, McMillan DC, Carter R, Imrie CW and McKay CJ: Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 6: 450-453, 2006. (Pubitemid 44624278)
34. Leitch EF, Chakrabarti M, Crozier JE, McKee RF, Anderson JH, Horgan PG and McMillan DC: Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer 97: 1266-1270, 2007. (Pubitemid 350035815)
35. McMillan DC, Crozier JE, Canna K, Angerson WJ and McArdle CS: Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 22: 881-886, 2007. (Pubitemid 46952036)
36. Crumley AB, McMillan DC, McKernan M, Going JJ, Shearer CJ and Stuart RC: An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer 94: 1568-1571, 2006. (Pubitemid 43924914)
37. Jamieson NB, Glen P, McMillan DC, McKay CJ, Foulis AK, Carter R and Imrie CW: Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer 92: 21-23, 2005. (Pubitemid 40188430)
38. Ishizuka M, Kita J, Shimoda M, Rokkaku K, Kato M, Sawada T and Kubota K: Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer. J Surg Oncol 100: 38-42, 2009.
39. Fujiwara Y, Shiba H, Furukawa K, Iida T, Haruki K, Gocho T, Wakiyama S, Hirohara S, Ishida Y, Misawa T, Ohashi T and Yanaga K: Glasgow prognostic score is related to blood transfusion requirements and postoperative complications in hepatic resection for hepatocellular carcinoma. Anticancer Res 30: 5129-5136, 2010.
40. McMillan DC, Scott HR, Watson WS, Preston T, Milroy R and McArdle CS: Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer 31: 101-105, 1998. (Pubitemid 28428069)
41. McMillan DC, Watson WS, O'Gorman P, Preston T, Scott HR and McArdle CS: Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39: 210-213, 2001. (Pubitemid 33694037)
42. Nozoe T, Matsumata T and Sugimachi K: Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol 23: 263-266, 2000. (Pubitemid 32428031)
43. Canna K, McArdle PA, McMillan DC, McNicol AM, Smith GW, McKee RF and McArdle CS: The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 92: 651-654, 2005. (Pubitemid 40460599)
44. Szabo G, Kodys K and Miller-Graziano CL: Elevated monocyte interleukin-6 (IL-6) production in immunosuppressed trauma patients. I. Role of Fc gamma RI cross-linking stimulation. J Clin Immunol 11: 326-335, 1991.
45. Balkwill F and Mantovani A: Cancer and inflammation: Implications for pharmacology and therapeutics. Clin Pharmacol Ther 87: 401-406, 2010.